US-based CDMO Alcami has agreed to acquire Tjoapack, a contract packaging organisation with facilities in Tennessee and the Netherlands.
Tjoapack has been a supplier of contract primary and secondary packaging solutions for more than 35 years, with packaging and labelling services including oral solid dose (blister and bottles), sterile injectables (vials, pre-filled syringes and auto-injectors) and kitting.
The company operates from facilities in Clinton, Tennessee and Etten-Leur, The Netherlands, with 23 packaging lines and employs more than 400 skilled personnel.
"This acquisition marks our first European expansion, which is an essential element of our investment strategy to expand our presence in the global market," said Patrick Walsh, Chair and CEO of Alcami.
Furthermore, this increased scale aligns with our growth and expansion in pharmaceutical testing lab services, drug product manufacturing and pharma storage service offerings at Alcami.
Alcami said in a statement that the acquisition will allow it to enhance its US supply chain redundancy and scalability for packaging and labelling while adding Qualified Person (QP) release services in Europe.
Tjoapack clients will gain access to Alcami's pharmaceutical testing, sterile and oral solid dose manufacturing and GMP-compliant storage, ensuring efficient global delivery of medicines with minimal supplier handoffs.
"This transaction represents an important next chapter for Tjoapack," said Dexter Tjoa, CEO of Tjoapack.
Partnering with Alcami allows us to accelerate our growth ambitions while staying true to what has made Tjoapack successful — quality, reliability and a strong focus on our customers.
"Together, we create a more integrated transatlantic platform that enables us to support our partners more effectively as they scale and expand globally."
The transaction is subject to customary closing conditions and is expected to close in the second quarter of this year.